S&P 500   2,999.70 (+0.33%)
DOW   27,036.31 (+0.13%)
QQQ   193.44 (+0.21%)
AAPL   234.33 (-0.02%)
FB   189.52 (-0.02%)
MSFT   139.63 (-0.56%)
GOOGL   1,255.77 (+1.03%)
AMZN   1,791.30 (+0.78%)
CGC   20.04 (+1.57%)
NVDA   193.98 (-0.12%)
MU   45.48 (+0.71%)
BABA   176.49 (-0.36%)
GE   9.09 (+2.14%)
TSLA   261.81 (+0.79%)
AMD   31.18 (+1.20%)
ACB   3.75 (+3.88%)
BAC   30.33 (+0.53%)
GILD   65.36 (+0.02%)
DIS   133.07 (+1.68%)
S&P 500   2,999.70 (+0.33%)
DOW   27,036.31 (+0.13%)
QQQ   193.44 (+0.21%)
AAPL   234.33 (-0.02%)
FB   189.52 (-0.02%)
MSFT   139.63 (-0.56%)
GOOGL   1,255.77 (+1.03%)
AMZN   1,791.30 (+0.78%)
CGC   20.04 (+1.57%)
NVDA   193.98 (-0.12%)
MU   45.48 (+0.71%)
BABA   176.49 (-0.36%)
GE   9.09 (+2.14%)
TSLA   261.81 (+0.79%)
AMD   31.18 (+1.20%)
ACB   3.75 (+3.88%)
BAC   30.33 (+0.53%)
GILD   65.36 (+0.02%)
DIS   133.07 (+1.68%)
Log in

DelMar Pharmaceuticals Price Target & Analyst Ratings (NASDAQ:DMPI)

$0.52
+0.07 (+15.56 %)
(As of 10/17/2019 11:30 AM ET)
Today's Range
$0.44
Now: $0.52
$0.57
50-Day Range
$0.41
MA: $0.57
$0.73
52-Week Range
$0.40
Now: $0.52
$7.00
Volume940,039 shs
Average Volume186,033 shs
Market Capitalization$1.38 million
P/E RatioN/A
Dividend YieldN/A
Beta1.25

Analyst Ratings

DelMar Pharmaceuticals (NASDAQ:DMPI) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for DelMar Pharmaceuticals in the last 12 months. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/A$120.00
Price Target Upside: N/AN/AN/A1,124.49% upside

DelMar Pharmaceuticals (NASDAQ:DMPI) Consensus Price Target History

DelMar Pharmaceuticals (NASDAQ:DMPI) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/6/2019Maxim GroupInitiated CoverageBuyHigh
7/11/2019Dawson JamesReiterated RatingBuyHigh
5/23/2018HC WainwrightSet Price TargetBuy$120.00Medium
(Data available from 10/17/2017 forward)
This page was last updated on 10/17/2019 by MarketBeat.com Staff

Featured Article: High-Yield Dividend Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel